Chemotherapy for Oral Cancer - 14/11/17
Résumé |
The use of chemotherapy, including immunotherapy, in oral squamous cell carcinoma has expanded considerably in the past several years. Its use mirrors that in the treatment of squamous cell carcinoma affecting other structures in the head and neck. This article summarizes the current evidence that guides use of chemotherapy both in combination with radiation and as monotherapy for patients with advanced disease. It also addresses the expanding role of immunotherapy, particularly use of programmed cell death-ligand 1 inhibitors, in the treatment of advanced disease.
Le texte complet de cet article est disponible en PDF.Keywords : Chemotherapy, Oral cancer, Chemoradiation, Cisplatin, Cetuximab, Nivolumab, Pembrolizumab
Plan
| Conflicts of Interest: None to report. |
Vol 62 - N° 1
P. 87-97 - janvier 2018 Retour au numéro
Article précédent
- Surgical Management of Oral Cancer
- Rabie M. Shanti, Bert W. O’Malley
- Radiation Therapy for Oral Cavity and Oropharyngeal Cancers
- Alexander Lin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?